AGR2
Basic information
Region (hg38): 7:16791811-16833433
Links
Phenotypes
GenCC
Source:
- respiratory infections, recurrent, and failure to thrive with or without diarrhea (Limited), mode of inheritance: AR
- respiratory infections, recurrent, and failure to thrive with or without diarrhea (Strong), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AGR2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 12 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 4 | 13 | 1 | 0 |
Variants in AGR2
This is a list of pathogenic ClinVar variants found in the AGR2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-16794972-G-T | not specified | Uncertain significance (Mar 29, 2023) | ||
7-16794986-C-T | Respiratory infections, recurrent, and failure to thrive with or without diarrhea | Pathogenic (Jan 31, 2023) | ||
7-16795011-G-C | not specified | Uncertain significance (Aug 08, 2023) | ||
7-16795017-G-T | not specified | Uncertain significance (Jul 10, 2023) | ||
7-16797667-G-T | not specified | Uncertain significance (Dec 22, 2023) | ||
7-16797676-G-A | Respiratory infections, recurrent, and failure to thrive with or without diarrhea | Likely pathogenic (Mar 14, 2024) | ||
7-16797693-T-C | Respiratory infections, recurrent, and failure to thrive with or without diarrhea | Uncertain significance (Mar 26, 2024) | ||
7-16797695-C-T | AGR2-related disorder | Uncertain significance (Feb 16, 2024) | ||
7-16799743-C-A | Respiratory infections, recurrent, and failure to thrive with or without diarrhea | Pathogenic (Jan 31, 2023) | ||
7-16799806-C-T | not specified | Uncertain significance (Oct 05, 2021) | ||
7-16801149-A-G | Respiratory infections, recurrent, and failure to thrive with or without diarrhea • AGR2-related disorder | Likely pathogenic (May 12, 2023) | ||
7-16801164-G-C | not specified | Uncertain significance (Jan 26, 2023) | ||
7-16801196-G-T | Respiratory infections, recurrent, and failure to thrive with or without diarrhea | Likely pathogenic (Mar 25, 2024) | ||
7-16801369-G-C | not specified | Uncertain significance (Mar 20, 2024) | ||
7-16801669-G-A | not specified | Uncertain significance (Sep 03, 2024) | ||
7-16801687-C-T | not specified | Likely benign (Feb 06, 2024) | ||
7-16801692-GT-G | Respiratory infections, recurrent, and failure to thrive with or without diarrhea | Likely pathogenic (Oct 04, 2024) | ||
7-16801702-TC-T | Respiratory infections, recurrent, and failure to thrive with or without diarrhea | Uncertain significance (May 20, 2023) | ||
7-16801703-C-G | not specified | Uncertain significance (Sep 12, 2023) | ||
7-16801735-C-A | not specified | Uncertain significance (Feb 27, 2023) | ||
7-16801763-G-A | not specified | Uncertain significance (Aug 08, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AGR2 | protein_coding | protein_coding | ENST00000419304 | 7 | 41623 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.24e-8 | 0.177 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.844 | 67 | 89.5 | 0.749 | 0.00000414 | 1131 |
Missense in Polyphen | 20 | 33.73 | 0.59294 | 429 | ||
Synonymous | 0.730 | 28 | 33.4 | 0.839 | 0.00000162 | 328 |
Loss of Function | 0.103 | 11 | 11.4 | 0.967 | 5.45e-7 | 140 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000904 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000132 | 0.000132 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Required for MUC2 post-transcriptional synthesis and secretion. May play a role in the production of mucus by intestinal cells (By similarity). Proto-oncogene that may play a role in cell migration, cell differentiation and cell growth. Promotes cell adhesion (PubMed:23274113). {ECO:0000250, ECO:0000269|PubMed:18199544, ECO:0000269|PubMed:23274113}.;
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- 0.625
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 42.88
Haploinsufficiency Scores
- pHI
- 0.0754
- hipred
- Y
- hipred_score
- 0.638
- ghis
- 0.446
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0406
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Agr2
- Phenotype
- hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- agr2
- Affected structure
- goblet cell
- Phenotype tag
- abnormal
- Phenotype quality
- immature
Gene ontology
- Biological process
- positive regulation of gene expression;positive regulation of cell-substrate adhesion;response to endoplasmic reticulum stress;positive regulation of epidermal growth factor receptor signaling pathway;digestive tract morphogenesis;positive regulation of developmental growth;lung goblet cell differentiation;negative regulation of cell death;mucus secretion;positive regulation of protein localization to plasma membrane;positive regulation of IRE1-mediated unfolded protein response;positive regulation of PERK-mediated unfolded protein response
- Cellular component
- extracellular space;endoplasmic reticulum
- Molecular function
- dystroglycan binding;epidermal growth factor receptor binding;protein binding;protein homodimerization activity